SCHEMBL2272006

SCHEMBL2272006

O=C(Nc1cc(-c2ccccc2)ccc1C(=O)O)c1ccc(-n2cccc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 3/20 0.62
SERPINE1 P05121 3/20 0.61
DHODH Q02127 1/20 0.60
HDAC1 Q13547 6/20 0.52
HDAC2 Q92769 2/20 0.52
HDAC3 O15379 1/20 0.51
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
SUCNR1 Q9BXA5 1/20 0.50
MEN1 O00255 1/20 0.50
MAPT P10636 1/20 0.50
PKM P14618 1/20 0.50
GRIK1 P39086 1/20 0.50
KMT2A Q03164 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
PDCD1 Q15116 1/20 0.48
CD274 Q9NZQ7 1/20 0.48
IGF2BP2 Q9Y6M1 1/20 0.47
SIRT6 Q8N6T7 1/20 0.47
AOC2 O75106 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2272853 0.96 ACLY (0.60) ACLYSERPINE1DHODHHDAC1HDAC2
SCHEMBL14428491 0.90 SERPINE1 (0.53) ACLYSERPINE1DHODHHDAC1HDAC2
SCHEMBL2270222 0.88 DHODH (0.77) ACLYSERPINE1DHODHHDAC1HDAC2
SCHEMBL2269037 0.88 ACLY (0.59) ACLYSERPINE1DHODHHDAC1HDAC2
SCHEMBL2273168 0.85 SERPINE1 (0.61) ACLYSERPINE1DHODHMEN1MAPT
SCHEMBL2275453 0.85 ACLY (0.76) ACLYSERPINE1DHODHHDAC1HDAC2
SCHEMBL2274895 0.85 ACLY (0.56) ACLYSERPINE1DHODHHDAC1HDAC2
SCHEMBL2275413 0.84 HDAC1 (0.50) ACLYSERPINE1DHODHHDAC1HDAC2
SCHEMBL2272605 0.83 DHODH (0.73) ACLYSERPINE1DHODHHDAC1HDAC2
SCHEMBL27696974 0.83 SERPINE1 (0.46) ACLYSERPINE1DHODHHDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101094829-B novel anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO.,LTD. (JP) 2012-02-08 CN disclosed
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
CN-101094829-A Novel anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO LTD (JP) 2007-12-26 CN disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 ACLY 653/4885SERPINE1 101/4885DHODH 1469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.